Notably, ER itself can be regulated by ACSL4, as ER expressions were reduced in MCF-7 Tet-Off/ACSL4 and restored upon treatment with doxycycline, suggesting ACSL4 negatively controls ER expression and mechanistically determines ER status in breast cancer along with its dependency on oestradiol [138]. This evidence concerns the gene ACSL4 and breast cancer.